Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics. Oh J, Bar-Or A, Montalban X, Sormani MP, et al. Lancet Neurol 2026;25:673-688.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oh J, Bar-Or A, Montalban X, Sormani MP, et al. Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics. Lancet Neurol 2026;25:673-688.
PMID: 42309088